FIELD: chemistry, pharmaceutics.
SUBSTANCE: invention relates to thieno[3,2-d]pyrimidine derivative of formula (I) or to its pharmaceutically acceptable salt: (I), where Y stands for -CH=CR1-, -C≡C- or -C(=O)NR1-; L stands for -C(=O)NR2-, -NR2C(=O)- or -NR2C(=O)NR2-; R1 and R2, each independently stands for H; R stands for H, a halogen atom, methyl or methoxy; E stands for phenyl or C3-10heteroaryl, which is non-substituted or substituted with 1-2 substituents, consisting of a group, which includes a halogen atom, -CF3, C1-6alkyl, hydroxy-C1-6alkyl, C3-8cycloalkyl, -(CH2)n-C1-6alkylamino, -(CH2)n-diC1-6alkylamino, -(CH2)nC1-6alkoxy, -(CH2)n-OS(=O)2-C1-6-alkyl, -(CH2)n-phenyl, -(CH2)n-C2-5heteroaryl and -(CH2)n-C4-6heterocycloalkyl, where C3-10heteroaryl represents pyridine, isoquinoline, indole or isoxazole, C2-5heteroaryl of radical -(CH2)n-C2-5heteroaryl represents imidazole or pyrrol, C4-6heterocycloalkyl of radical -(CH2)n-C4-6heterocycloalkyl represents piperazine, morpholine, diazepam, pyrrolidine or piperidine, and phenyl, heteroaryl and heterocycloalkyl each independently, is non-substituted or substituted with substituent selected from a group, which consists of C1-6alkyl, hydroxy-C1-6alkyl, a halogen atom and diC1-6alkylamino, n is equal to 0 or 1; and Z stands for H, -C(=O)R3, C1-6alkyl, hydroxyC1-6alkyl, C3-8cycloalkyl, piperidine, phenyl or pyridine, where piperidine, phenyl and pyridine, each independently, is non-substituted or substituted with C1-6alkyl, C1-6alkoxy or R3-piperazinyl and R3 represents C1-6alkyl or phenyl. The invention also relates to an intermediate compound for obtaining the claimed final compound of formula (I).
EFFECT: novel compound, which can be applied in medicine for the prevention or treatment of diseases, characterised by an anomalous growth of cells as a result of an excessive expression of proteinkinase, is obtained.
8 cl, 2 tbl, 128 ex
Title | Year | Author | Number |
---|---|---|---|
TIENOPYRIMYDINE [3,2-D] PRODUCTION, WHICH HAS INHIBITORY ACTIVITY AGAINST PROTEIN KINASES | 2012 |
|
RU2625799C2 |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES WITH PROTEIN KINASE INHIBITORY ACTIVITY | 2012 |
|
RU2705577C2 |
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2585177C2 |
NOVEL AMIDE DERIVATIVE FOR INHIBITING GROWTH OF CANCER CELLS | 2008 |
|
RU2434010C2 |
TRICYCLIC NITROGEN-CONTAINING DERIVATIVES OF IMIDAZO[4,5-C]PYRIDINE, HAVING INHIBITING ACTIVITY IN RESPONSE TO HYSTAMINE 4 RECEPTOR (HH4R) | 2012 |
|
RU2628074C2 |
NOVEL DERIVATIVES OF 1,3-DIHYDRO-5-ISOBENZOFURANCARBONITRYL AND BASED ON THEM PHARMACEUTICAL COMPOSITION FOR TREATING PREMATURE EJACULATION | 2008 |
|
RU2448963C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
BENZOTHIAZOLE COMPOUNDS AND METHODS FOR THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | 2018 |
|
RU2778370C2 |
DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING | 2001 |
|
RU2263676C2 |
NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITING ACTIVITY | 2019 |
|
RU2768755C1 |
Authors
Dates
2014-07-27—Published
2011-01-31—Filed